Gabify
New Delhi
About Gabify
Gabify is an AI-powered health-tech SaaS platform focused on early detection, assessment, and monitoring of neurodevelopmental and speech-language disorders in children, including Autism Spectrum Disorder (ASD), ADHD, and speech delays. By leveraging artificial intelligence, behavioral analytics, and clinically validated frameworks, Gabify enables scalable, data-driven screening through digital tools and mobile applications. The platform integrates with schools, therapy centers, hospitals, and parents to facilitate early identification, personalized insights, and timely intervention. Gabify’s ecosystem connects key stakeholders’families, therapists, educators, and healthcare institutions’bridging critical gaps in accessibility, affordability, and awareness of developmental care. Through partnerships with clinical experts and institutions, Gabify supports evidence-based decision-making and enhances outcomes for children with developmental challenges. With a mission to democratize early diagnosis and inclusive healthcare, Gabify is building the digital infrastructure for neurodevelopmental care across emerging and global markets, empowering communities with technology-driven solutions for early intervention and lifelong impact.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Total funding: $217.3K
- Funding stage: Seed
- Last round: Pre-Seed (Apr 2026)
- Website: gabify.life
- Phone: 9266034111
Social Profiles
Canonical: https://fsome.com/organization/gabify-2412311 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.